J&J | JNJ - Current Liabilities


J&J reported $54.9B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
AbbVie USD 41.64B 458M Jun/2026
Abbott USD 18.38B 1.88B Mar/2026
Amgen USD 25.5B 547M Jun/2026
AstraZeneca USD 31.55B 1.02B Jun/2026
Baxter International USD 3.59B 102M Jun/2026
Bayer EUR 32.27B 1.19B Jun/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Biogen USD 3.92B 918.2M Jun/2026
Boston Scientific USD 6.43B 1.86B Jun/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
CONMED USD 455.4M 162.68M Jun/2026
Cooper Companies USD 1.87B 61.9M Jun/2026
Dexcom USD 2.36B 133.9M Jun/2026
Edwards Lifesciences USD 1.51B 98.9M Jun/2026
Eli Lilly USD 47.74B 11.11B Jun/2026
Gilead Sciences USD 11.02B 1.54B Jun/2026
GlaxoSmithKline GBP 21.53B 895M Jun/2026
Globus Medical USD 479.35M 3.12M Jun/2026
Insulet USD 744.2M 56.7M Jun/2026
Integra LifeSciences USD 330.88M 15.96M Jun/2026
Intuitive Surgical USD 2.58B 65.1M Jun/2026
J&J USD 54.9B 2.82B Jun/2026
Medtronic USD 11.8B 141M Jun/2026
Merck USD 27.73B 786M Jun/2026
Merit Medical Systems USD 264.93M 48.06M Jun/2026
Novartis USD 31.75B 374M Jun/2026
Pfizer USD 32.65B 1.7B Jun/2026
Regeneron Pharmaceuticals USD 5.53B 422.9M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026
Stryker USD 6.68B 369M Jun/2026
Tandem Diabetes Care USD 253M 5.05M Jun/2026
Teva Pharmaceutical Industries USD 15.65B 2.11B Jun/2026
Vertex Pharmaceuticals USD 3.94B 57.3M Jun/2026
Zimmer Biomet Holdings USD 3.01B 149.2M Jun/2026
Zoetis USD 2.06B 8M Jun/2026